| Literature DB >> 24093352 |
Shwetha S Sequeira1, Laura H P Eggermont, Rebecca A Silliman, Timothy W Bickmore, Lori E Henault, Michael R Winter, Kerrie Nelson, Michael K Paasche-Orlow.
Abstract
Limited health literacy is associated with worse executive function, but the association between limited health literacy and decline in executive function has not been established because of a lack of longitudinal studies. The authors aimed to examine this association by studying a prospective cohort in the setting of a randomized controlled trial to promote walking in older adults. Participants were community-dwelling older adults (65 years of age or older) who scored 2 or more on the Mini-Cog, without depression (score of less than 15 on the 9-item Patient Health Questionnaire), and who completed baseline and 12-month evaluations (n = 226). Health literacy was measured using the Short Test of Functional Health Literacy in Adults. Executive function measured at baseline and 12 months using the Trail Making Test (TMT), Controlled Oral Word Association Test, and Category Fluency. The associations between health literacy and 12-month decline in each test of executive function were modeled using multivariate linear regression. Health literacy was found to be limited in 37% of participants. Limited health literacy was associated with reduced performance on all 3 executive function tests. In fully adjusted models, limited health literacy was associated with greater 12-month decline in performance on the TMT than higher health literacy (p = .01). In conclusion, older adults with limited health literacy are at risk for more rapid decline in scores on the TMT, a measure of executive function.Entities:
Mesh:
Year: 2013 PMID: 24093352 PMCID: PMC3807941 DOI: 10.1080/10810730.2013.825673
Source DB: PubMed Journal: J Health Commun ISSN: 1081-0730
Demographic information
| Total ( | Limited health literacy ( | Higher health literacy ( | Chi-square statistic ( | ||
|---|---|---|---|---|---|
| Randomization | 0.143 (1) | .705 | |||
| Control | 114 (50.4) | 41 (48.8) | 73 (51.4) | ||
| Intervention | 112 (49.6) | 43 (51.2) | 69 (48.6) | ||
| Age (years) | 1.132 (3) | .769 | |||
| 65–69 | 105 (46.5) | 39 (46.4) | 66 (46.5) | ||
| 70–74 | 57 (25.2) | 24 (28.6) | 33 (23.2) | ||
| 75–79 | 45 (19.9) | 15 (17.9) | 30 (21.1) | ||
| 80+ | 19 (8.4) | 6 (7.1) | 13 (9.2) | ||
| Sex | 0.108 (1) | .742 | |||
| Female | 143 (63.3) | 52 (61.9) | 91 (64.1) | ||
| Race | 45.538 (2) | <.001 | |||
| Black | 142 (62.8) | 76 (90.5) | 66 (46.5) | ||
| White | 67 (29.6) | 4 (4.8) | 63 (44.4) | ||
| Other | 17 (7.5) | 4 (4.8) | 13 (9.2) | ||
| Education | 46.530 (2) | <.001 | |||
| Less than high school | 48 (21.2) | 34 (40.5) | 14 (9.9) | ||
| High school | 68 (30.1) | 32 (38.1) | 36 (25.4) | ||
| More than high school | 110 (48.7) | 18 (21.4) | 92 (64.8) | ||
| Number of comorbidities | 8.222 (2) | .016 | |||
| None | 107 (47.3) | 30 (35.7) | 77 (54.2) | ||
| 1 | 63 (27.9) | 26 (31.0) | 37 (26.1) | ||
| 2+ | 56 (24.8) | 28 (33.3) | 28 (19.7) | ||
| PHQ-9 score | 4.928 (2) | .085 | |||
| Minimal (1–4) | 186 (82.3) | 63 (75.0) | 123 (86.6) | ||
| Mild (5–9) | 30 (13.3) | 16 (19.0) | 14 (9.9) | ||
| Moderate (10–14) | 10 (4.4) | 5 (6.0) | 5 (3.5) |
Test statistic, df, and p value from chi-square test.
Comorbidities from chart review: Myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, connective tissue disease, ulcer disease, diabetes mellitus, diabetes with end organ damage, moderate or severe renal disease, mild liver disease, moderate or severe liver disease, malignancy.
PHQ-9 = nine-item Patient Health Questionnaire.
Executive function at baseline and 12-month follow-up, by health literacy
| Time | Limited health literacy ( | Higher health literacy ( | ||
|---|---|---|---|---|
| Delta Trail Making Test (seconds), | ||||
| Baseline | 159.2 (68.2) | 84.5 (59.0) | 8.62 (222) | <.001 |
| 12 months | 178.1 (58.6) | 93.6 (67.1) | 9.50 (222) | <.001 |
| Change | 18.8 (65.5) | 9.1 (52.3) | 1.14 (136) | .258 |
| FAS (average number), | ||||
| Baseline | 22.0 (10.5) | 34.3 (12.9) | −7.71 (202) | <.001 |
| 12 months | 22.2 (11.0) | 35.3 (13.4) | −7.49 (222) | <.001 |
| Change | 0.02 (9.4) | 1.1 (9.2) | −0.83 (221) | .407 |
| Category Fluency (average number), | ||||
| Baseline | 24.1 (6.0) | 29.8 (7.9) | −6.04 (211) | <.001 |
| 12 months | 23.7 (6.8) | 29.5 (8.2) | −5.48 (223) | <.001 |
| Change | −0.5 (5.2) | −0.2 (5.5) | −0.40 (223) | .686 |
Test statistic and p value from two-sided t test.
Delta Trail Making Test: Time in seconds for TMT B (draw lines sequentially connecting 25 alternating numbers and letters) minus time in seconds for TMT A (draw lines sequentially connecting 25 encircled numbers). Maximum time allotted is 150 s for TMT A and 300 s for TMT B.
FAS: Number of words that begin with letters F, A, and S in three separate, 1 minute trials. Proper nouns and incorrect words excluded from final score, which is average of the three trials.
Category Fluency: Number of animals and vegetables named in two separate 1-min trials. The final score is average of the two trials.
Change: Score at 12-month follow-up minus score at baseline.
Linear regression for change in executive function from baseline to 12 months
| Change in delta LML | Change in FAS | Change in category fluency | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | |||||||||
| Health literacy | |||||||||
| Low | 23.8 (5.3,42.2) | 6.46 (1,204) | .012 | −1.8 (−4.8, 1.2) | 1.44 (1,205) | .232 | −0.4 (−2.2, 1.3) | 0.22 (1,207) | .641 |
| High (ref) | |||||||||
| Baseline scores | −0.5 (−0.6, −0.3) | 59.61 (1,204) | <.001 | −0.3 (−0.4, −0.2) | 26.90 (1,205) | <.001 | −0.2 (−0.4,−0.1) | 21.26 (1,207) | <.001 |
| Randomization | |||||||||
| Intervention | 9.2 (−4.7, 23.1) | 1.71 (1,204) | .193 | 0.2 (−2.1, 2.6) | 0.04 (1,205) | .841 | −0.5 (4.9,0.9) | 0.46 (1,207) | .500 |
| Control (ref) | |||||||||
| Clinic¶ | |||||||||
| Clinic 2 | −12.2 (−32.5, 8.1) | 2.43 (2, 204) | .090 | −2.1 (−5.5, 1.2) | 9.20 (2, 205) | <.001 | 0.6 (4.4,2.6) | 0.80 (2, 207) | .449 |
| Clinic 3 | −22.8 (−48.0, 2.4) | 5.4 (1.2,9.6) | 1.3 (1−2,3.9) | ||||||
| Clinic 1 (ref) | |||||||||
| Age (years) | |||||||||
| 70−74 | −1.2 (−23.9, 21.6) | 0.50 (3, 204) | .685 | 0.4 (−3.5, 4.2) | 1.46 (3,205) | .227 | −0.7 (−2.9, 1.6) | 2.57 (3, 207) | .055 |
| 75−79 | 10.2 (−14.6, 35.0) | 0.3 (−3.9, 4.4) | 0.5 (−2.0, 2.9) | ||||||
| 80+ | 0.2 (−35.9, 36.3) | −4.3 (−10.3, 1.8) | −3.4 (−6.9, 0.2) | ||||||
| 65−69 (ref) | |||||||||
| Sex | |||||||||
| Female | −15.4 (−30.2,−0.6) | 4.21 (1,204) | .042 | 1.1 (−1.4,3.5) | 0.71 (1,205) | .400 | 0.3 (4.2, 1.8) | 0.13 (1,207) | .714 |
| Race | |||||||||
| Black | 15.6 (−7.3, 38.7) | 1.30 (2,204) | .274 | −4.9 (−8.7,−1.0) | 4.53 (2, 205) | .012 | −1.2 (−3.6, 1.1) | 0.81 (2, 207) | .446 |
| Other | 7.1 (−28.8,42.9) | −3.2 (−9.0, 2.6) | −1.2 (−4.7, 2.3) | ||||||
| White (ref) | |||||||||
| Education | |||||||||
| Less than high school | 26.0 (1.6,50.4) | 3.17 (2,204) | .044 | −2.7 (−6.7, 1.3) | 1.49 (2,205) | .229 | −1.7 (−4.1, 0.7) | 1.50 (2,207) | .226 |
| High school | 10.7 (−10−0, 31.4) | −0.1 (−3.4, 3.3) | −0.3 (−2.3, 1.8) | ||||||
| More than high school (ref) | |||||||||
| Number of Comorbidities | |||||||||
| 1 | 3.9 (−15.6,23.5) | 1.42 (2,204) | .244 | −0.2 (−3.4, 3.1) | 0.30 (2, 205) | .743 | −1.2 (−3.2, 0.8) | 1.48 (2,207) | .231 |
| 2+ | 14.9 (−6.0,35.9) | 1.0 (−2.5, 4.5) | −1.2 (−3.3, 0.9) | ||||||
| 0 (ref) | |||||||||
| PHQ-9 | |||||||||
| Mild (5−9) | −9.4 (−34.3,15.5) | 0.43 (2, 204) | .653 | 0.3 (−3.9, 4.6) | 0.81 (2, 205) | .447 | 0.7 (−1.9, 3.1) | 2.10 (2,207) | .125 |
| Moderate (10−14) | 2.7 (−40.1, 45.5) | 3.6 (−3.1, 10.3) | 3.5 (−0.6, 7.5) | ||||||
| Minimal (1−4) (ref) | |||||||||
| 0.28 | 0.24 | 0.17 | |||||||
| 4.77 (17, 204) | 3.71 (17,205) | 2.48 (17, 207) | |||||||
| <.001 | <.001 | .001 | |||||||
Change in delta TMT: Delta TMT score at 12-month follow-up minus score at baseline, in seconds. A greater increase in time for delta TMT indicates more rapid decline in executive function.
Change in FAS: Score at 12-month follow-up minus score at baseline, average number. Greater decrease in average number for FAS indicates more rapid decline in executive function.
Change in Category Fluency: Score at 12-month follow-up minus score at baseline, average number. Greater decrease in average number named for Category Fluency indicates more rapid decline in executive function.
Tukey adjusted confidence intervals (except for Baseline scores).
Global p value (from Type III F statistic for variable).
Clinic location: Clinic 1 and Clinic 2 – Internal medicine clinics, Clinic 3 – Geriatrics clinic.
Comorbidities from chart review: Myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, connective tissue disease, ulcer disease, diabetes mellitus, diabetes with end organ damage, moderate or severe renal disease, mild liver disease, moderate or severe liver disease, malignancy.
PHQ-9 = nine-item Patient Health Questionnaire.